Pro Medicus Stock Shares Owned By Insiders
| PME Stock | 221.75 7.13 3.32% |
Pro Medicus fundamentals help investors to digest information that contributes to Pro Medicus' financial success or failures. It also enables traders to predict the movement of Pro Stock. The fundamental analysis module provides a way to measure Pro Medicus' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Pro Medicus stock.
Pro | Shares Owned By Insiders |
Pro Medicus Company Shares Owned By Insiders Analysis
Pro Medicus' Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Pro Medicus Shares Owned By Insiders | 51.20 % |
Most of Pro Medicus' fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pro Medicus is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
| Competition |
Based on the latest financial disclosure, 51% of Pro Medicus are shares owned by insiders. This is much higher than that of the Health Care Technology sector and significantly higher than that of the Health Care industry. The shares owned by insiders for all Australia stocks is notably lower than that of the firm.
Pro Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Pro Medicus' direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Pro Medicus could also be used in its relative valuation, which is a method of valuing Pro Medicus by comparing valuation metrics of similar companies.Pro Medicus is currently under evaluation in shares owned by insiders category among its peers.
Pro Fundamentals
| Return On Equity | 0.51 | ||||
| Return On Asset | 0.31 | ||||
| Profit Margin | 0.51 % | ||||
| Operating Margin | 0.73 % | ||||
| Current Valuation | 23.02 B | ||||
| Shares Outstanding | 104.5 M | ||||
| Shares Owned By Insiders | 51.20 % | ||||
| Shares Owned By Institutions | 14.17 % | ||||
| Price To Book | 123.44 X | ||||
| Price To Sales | 143.48 X | ||||
| Revenue | 161.5 M | ||||
| Gross Profit | 126.79 M | ||||
| EBITDA | 120.76 M | ||||
| Net Income | 82.79 M | ||||
| Total Debt | 2.07 M | ||||
| Book Value Per Share | 1.80 X | ||||
| Cash Flow From Operations | 86.78 M | ||||
| Earnings Per Share | 0.80 X | ||||
| Target Price | 152.71 | ||||
| Beta | 0.54 | ||||
| Market Capitalization | 23.17 B | ||||
| Total Asset | 257.43 M | ||||
| Retained Earnings | 173.36 M | ||||
| Working Capital | 172 M | ||||
| Annual Yield | 0 % | ||||
| Net Asset | 257.43 M | ||||
| Last Dividend Paid | 0.4 |
About Pro Medicus Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Pro Medicus's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pro Medicus using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pro Medicus based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Pro Stock Analysis
When running Pro Medicus' price analysis, check to measure Pro Medicus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pro Medicus is operating at the current time. Most of Pro Medicus' value examination focuses on studying past and present price action to predict the probability of Pro Medicus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pro Medicus' price. Additionally, you may evaluate how the addition of Pro Medicus to your portfolios can decrease your overall portfolio volatility.